🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

719 results for “LI” Clear

  1. retapamulin

    ALTARGO Almirall, S.A.

    TOPICAL FDA: approved · EMA: withdrawn

    D06AX13

  2. retifanlimab

    ZYNYZ

    EMA: approved

    L01FF10

  3. retifanlimab-dlwr

    ZYNYZ

    INTRAVENOUS FDA: approved

  4. ribociclib

    KISQALI Novartis Pharmaceuticals

    ORAL FDA: approved · EMA: approved · TGA: approved

    L01EF02

  5. ribociclib succinate

    KISQALI

    ORAL FDA: approved

  6. rosiglitazone

    AVANDAMET

    EMA: unknown

    A10BD03

  7. rosiglitazone maleate

    ROSIGLITAZONE MALEATE

    ORAL FDA: approved

  8. rotavirus vaccine, live

    ROTARIX

    EMA: approved

    J07BH01

  9. rozanolixizumab

    RYSTIGGO

    EMA: approved

    L04AL02

  10. rozanolixizumab-noli

    RYSTIGGO

    SUBCUTANEOUS FDA: approved

  11. ruxolitinib

    JAKAVI Novartis Pharmaceuticals

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    D11AH

  12. ruxolitinib phosphate

    JAKAFI XR

    TOPICAL FDA: approved

  13. salicylic acid

    NULL

    TGA: approved

  14. salicylic acid (extemporaneous formula)

    NULL

    TGA: approved

  15. salicylic acid + lactic acid

    DUOFILM SOLUTION GlaxoSmithKline

    TGA: approved

  16. salicylic acid and sulfur aqueous

    NULL

    TGA: approved

  17. salicylic acid ointment

    NULL

    TGA: approved

  18. saline

    NMPA: clinical trials

  19. sarecycline

    NMPA: clinical trials

  20. sarecycline hydrochloride

    SEYSARA Almirall, S.A.

    ORAL FDA: approved

  21. sasanlimab

    ZUMRAD

    EMA: application withdrawn

    L01FF

  22. satralizumab

    ENSPRYNG

    INJECTION FDA: approved · EMA: approved · PMDA: approved · NMPA: clinical trials

    L04AC

  23. saxagliptin

    ONGLYZA AstraZeneca

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    A10BD21

  24. saxagliptin + dapagliflozin

    QTERN 5/10 AstraZeneca

    TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources